Metavia Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.17

-0.05 (-4.10%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +579.5% upside

Low Target $5.82

Average Target $7.95

High Target $9.13

Current Price $1.17

Current
$1.17

Target
$7.95

$5.82 $7.95 avg $9.13

Scenario Analysis

Bear Case

$5.82

397.4%

Low target

Base Case

$7.95

+579.5%

Avg target

Bull Case

$9.13

+680.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$23.10

-94.9% from high

52-Week Low

$1.22

+-3.8% from low

Target vs 52W High

$7.95

-65.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%